Vaxart, Inc. (VXRT) research
Vaxart, Inc.- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $0.44
- As of
Vaxart, Inc. (VXRT): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-09-14.
As of . Source: SEC EDGAR filings for VXRT. Method and limitations.
Share the VXRT intelligence card
See the full VXRT dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for VXRT on one page. Preview it with sample data, then open it live with a free account.
Preview the VXRT dossierActive signals for VXRT
- mediumEARNINGS_BEAT
Q2-2026: Beat consensus by 50.4%, EPS $-0.06 vs $-0.1209 estimate
- mediumEARNINGS_MISS
Q4-2025: Missed consensus by 96.1% - EPS $-0.1 vs $-0.051 estimate
- mediumEARNINGS_BEAT
Q2-2025: Beat consensus by 20.2% - EPS $-0.07 vs $-0.0877 estimate
- mediumEARNINGS_BEAT
Q3-2025: Beat consensus by 40.6% - EPS $-0.04 vs $-0.0673 estimate
- mediumEARNINGS_MISS
Missed consensus by 96.1% - EPS $-0.1 vs $-0.051 estimate
FREE, NO ACCOUNT
Every signal on VXRT, as it fires
New filings, 13F moves and cross asset signals on VXRT land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter. Historical quarters remain available above.
Recent SEC filings, VXRT
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
VXRT against its peers
VXRT's operating margin of 7.6% ranks in the 83rd percentile of 8 Biotechnology sub-industry peers, fiscal periods ending between 2025-06-30 and 2026-01-31.
| Metric | VXRT | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 237M USD | 2.0M USD | 96 | 11 |
| Operating margin | 7.6% | -442.9% | 83 | 8 |
| Net margin | 6.9% | -430.3% | 85 | 9 |
| Return on equity | 18.6% | -96.9% | 92 | 18 |
| P / E | 6.2x | n/a | n/a | 1 |
Peers (22): PYPD, KZIA, BDTX, IMUX, AARD, OKUR, MNOV, CBUS, LENZ, VANI, MIST, NTRB, GNLX, PLYX, COYA, UNCY, ANIX, CRBP, FHTX, PMN, VTVT, NMRA. Left out: CNXU (no annual filing), SPRC (period gap), HSTC (period gap). Fiscal periods ending between 2025-06-30 and 2026-01-31. Every figure is one full fiscal year read from one annual filing (VXRT: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
See more VXRT signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to VXRTand get the insider, 13F, options, and confluence read in one view.